1. Home
  2. CUE vs WCT Comparison

CUE vs WCT Comparison

Compare CUE & WCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUE
  • WCT
  • Stock Information
  • Founded
  • CUE 2014
  • WCT 2012
  • Country
  • CUE United States
  • WCT Hong Kong
  • Employees
  • CUE N/A
  • WCT N/A
  • Industry
  • CUE Biotechnology: Pharmaceutical Preparations
  • WCT
  • Sector
  • CUE Health Care
  • WCT
  • Exchange
  • CUE Nasdaq
  • WCT NYSE
  • Market Cap
  • CUE 94.4M
  • WCT 100.9M
  • IPO Year
  • CUE 2018
  • WCT 2024
  • Fundamental
  • Price
  • CUE $1.32
  • WCT $2.42
  • Analyst Decision
  • CUE Strong Buy
  • WCT
  • Analyst Count
  • CUE 5
  • WCT 0
  • Target Price
  • CUE $5.00
  • WCT N/A
  • AVG Volume (30 Days)
  • CUE 195.8K
  • WCT 3.7M
  • Earning Date
  • CUE 03-10-2025
  • WCT 12-07-2024
  • Dividend Yield
  • CUE N/A
  • WCT N/A
  • EPS Growth
  • CUE N/A
  • WCT N/A
  • EPS
  • CUE N/A
  • WCT 0.05
  • Revenue
  • CUE $9,532,000.00
  • WCT $2,370,163.00
  • Revenue This Year
  • CUE $73.11
  • WCT N/A
  • Revenue Next Year
  • CUE $11.02
  • WCT N/A
  • P/E Ratio
  • CUE N/A
  • WCT $52.43
  • Revenue Growth
  • CUE 149.53
  • WCT N/A
  • 52 Week Low
  • CUE $0.45
  • WCT $0.94
  • 52 Week High
  • CUE $2.37
  • WCT $9.36
  • Technical
  • Relative Strength Index (RSI)
  • CUE 48.32
  • WCT N/A
  • Support Level
  • CUE $1.22
  • WCT N/A
  • Resistance Level
  • CUE $1.54
  • WCT N/A
  • Average True Range (ATR)
  • CUE 0.11
  • WCT 0.00
  • MACD
  • CUE -0.01
  • WCT 0.00
  • Stochastic Oscillator
  • CUE 35.29
  • WCT 0.00

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.

About WCT WELLCHANGE HOLDINGS COMPANY LIMITED

Wellchange Holdings Co Ltd is an enterprise software solution services provider. It provides software solutions, cloud-based software-as-a-service (SaaS) platforms, and white-label software design and development services.

Share on Social Networks: